Back to Search Start Over

Ginsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis.

Authors :
Lin, Lifan
Li, Xinmiao
Li, Yifei
Lang, Zhichao
Li, Yeping
Zheng, Jianjian
Source :
Journal of Pharmaceutical Analysis; May2024, Vol. 14 Issue 5, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Liver fibrosis is primarily driven by the activation of hepatic stellate cells (HSCs), a process associated with ferroptosis. Ginsenoside Rb1 (GRb1), a major active component extracted from Panax ginseng, inhibits HSC activation. However, the potential role of GRb1 in mediating HSC ferroptosis remains unclear. This study examined the effect of GRb1 on liver fibrosis both in vivo and in vitro , using CCl 4 -induced liver fibrosis mouse model and primary HSCs, LX-2 cells. The findings revealed that GRb1 effectively inactivated HSCs in vitro , reducing alpha-smooth muscle actin (α-SMA) and type I collagen (Col1A1) levels. Moreover, GRb1 significantly alleviated CCl 4 -induced liver fibrosis in vivo. From a mechanistic standpoint, the ferroptosis pathway appeared to be central to the antifibrotic effects of GRb1. Specifically, GRb1 promoted HSC ferroptosis both in vivo and in vitro , characterized by increased glutathione depletion, malondialdehyde production, iron overload, and accumulation of reactive oxygen species (ROS). Intriguingly, GRb1 increased Beclin 1 (BECN1) levels and decreased the System Xc-key subunit SLC7A11. Further experiments showed that BECN1 silencing inhibited GRb1-induced effects on HSC ferroptosis and mitigated the reduction of SLC7A11 caused by GRb1. Moreover, BECN1 could directly interact with SLC7A11, initiating HSC ferroptosis. In conclusion, the suppression of BECN1 counteracted the effects of GRb1 on HSC inactivation both in vivo and in vitro. Overall, this study highlights the novel role of GRb1 in inducing HSC ferroptosis and promoting HSC inactivation, at least partly through its modulation of BECN1 and SLC7A11. [Display omitted] • GRb1 effectively inactivated HSC and alleviated CCl 4 -induced liver fibrosis. • GRb1 promotes HSC inactivation via ferroptosis pathway, and this is a first report. • BECN1 is the key medium in the ferroptosis process induced by GRb1. • GRb1-induced HSC ferroptosis is via BECN1/SLC7A11 axis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20951779
Volume :
14
Issue :
5
Database :
Supplemental Index
Journal :
Journal of Pharmaceutical Analysis
Publication Type :
Academic Journal
Accession number :
177601178
Full Text :
https://doi.org/10.1016/j.jpha.2023.11.009